The underlying molecular mechanism involves the activation of CRH-1/CREB by CMK-1/CaMKI in AFD neurons, which in turn upregulates the FMRFamide neuropeptide (FLP-6) that acts on AIY interneurons [49] (Figure 1). The gene discussed is CREB1; the disease is Nager acrofacial dysostosis.